The following fines are imposed on the undertakings named in Article 1 in respect of the infringement referred to therein:
(a)
Rhone Poulenc Biochimie SA and Aventis Pharma SA, jointly and severally liable, a fine of EUR 2,85 million;
(b)
Merck KgaA, a fine of EUR 0 million.